110 related articles for article (PubMed ID: 17237283)
1. Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system.
Fukazawa T; Maeda Y; Durbin ML; Nakai T; Matsuoka J; Tanaka H; Naomoto Y; Tanaka N
Mol Cancer Ther; 2007 Jan; 6(1):244-52. PubMed ID: 17237283
[TBL] [Abstract][Full Text] [Related]
2. Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
Fukazawa T; Maeda Y; Matsuoka J; Tanaka N; Tanaka H; Durbin ML; Naomoto Y
Int J Cancer; 2009 Oct; 125(8):1975-84. PubMed ID: 19598260
[TBL] [Abstract][Full Text] [Related]
3. Development of a cancer-targeted tissue-specific promoter system.
Fukazawa T; Maeda Y; Sladek FM; Owen-Schaub LB
Cancer Res; 2004 Jan; 64(1):363-9. PubMed ID: 14729646
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like Particles.
Chao CN; Lin MC; Fang CY; Chen PL; Chang D; Shen CH; Wang M
PLoS One; 2016; 11(6):e0157865. PubMed ID: 27322500
[TBL] [Abstract][Full Text] [Related]
5. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
Fukazawa T; Maeda Y; Matsuoka J; Ono T; Mominoki K; Yamatsuji T; Shigemitsu K; Morita I; Murakami I; Tanaka H; Durbin ML; Naomoto Y
Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells.
Kaliberov SA; Buchsbaum DJ; Gillespie GY; Curiel DT; Arafat WO; Carpenter M; Stackhouse MA
Mol Ther; 2002 Aug; 6(2):190-8. PubMed ID: 12161185
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue.
Rucka Z; Vanhara P; Koutna I; Tesarova L; Potesilova M; Stejskal S; Simara P; Dolezel J; Zvonicek V; Coufal O; Capov I
Int J Mol Med; 2013 Jul; 32(1):211-8. PubMed ID: 23620014
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element.
Alcorn JL; Islam KN; Young PP; Mendelson CR
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L767-76. PubMed ID: 14633512
[TBL] [Abstract][Full Text] [Related]
9. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene.
Alcorn JL; Gao E; Chen Q; Smith ME; Gerard RD; Mendelson CR
Mol Endocrinol; 1993 Aug; 7(8):1072-85. PubMed ID: 8232306
[TBL] [Abstract][Full Text] [Related]
10. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
12. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
Tai YT; Strobel T; Kufe D; Cannistra SA
Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells.
Hoover RR; Thomas KH; Floros J
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):69-76. PubMed ID: 10229660
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glucocorticoids.
Losada A; Tovar JA; Xia HM; Diez-Pardo JA; Santisteban P
Endocrinology; 2000 Jun; 141(6):2166-73. PubMed ID: 10830305
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells.
Aydin C; Sanlioglu AD; Karacay B; Ozbilim G; Dertsiz L; Ozbudak O; Akdis CA; Sanlioglu S
Hum Gene Ther; 2007 Jan; 18(1):39-50. PubMed ID: 17187448
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
19. PTGDR gene expression and response to dexamethasone treatment in an in vitro model.
Marcos-Vadillo E; García-Sánchez A; Sanz C; Davila I; Isidoro-García M
PLoS One; 2017; 12(10):e0186957. PubMed ID: 29088248
[TBL] [Abstract][Full Text] [Related]
20. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
